Well, after spending last month catching up and revising my thoughts and opinions about the dozens of stocks I’ve covered for the Irregulars in this space, it’s time to again look for something interesting for your consideration. First, I should let you know that I’ve become less worried about about Seadrill (SDRL) this week after […]
Articles
- Most Relevant
- Most Recent
Today I continue my annual navel-gazing for you, as I look at each position in my portfolio — though this year, as I mentioned in our kickoff last week, I’m changing the way I describe, report and follow these stocks for you, largely so that I can be clearer about my preferences and opinions and […]
I’ve spent the past couple weeks going over my updated opinions on all of the past “Idea of the Month” stocks (or at least, those that haven’t already been dropped from coverage over the years), and I promised to put them all in one big list in order of likingness (yes, I know it’s not […]
Brazil’s economy is finally growing now, a growth that it started getting credit for a few years ago, before the expansion really started — five years ago, it was enough that Brazil under President Lula seemed to have a handle on inflation and a reasonably pro-business government. Now, it’s one of the few large, stable […]
Guy Gottfried has a nice, albeit short, record of choosing excellent little Canadian value stocks that have risen in value pretty substantially over the year or so following his presentation. Of course, that doesn’t mean his pick this year will jump right up — but he’s presenting before the market opens, and the 500 or […]
Over the years I’ve shared a few “Idea of the Month” picks that are plays on various emerging markets — the most direct emerging and frontier market picks have been Lonrho in Africa, Brazil Fast Food in Brazil, and Nagacorp in Cambodia, so let’s check in with those. As with the rest of our annual […]
Today we’ve had two good presentations at the Value Investing Congress so far — one from Lloyd Khaner with a pretty compelling argument that Jamba Juice (JMBA) has gone through the first three years of turnaround and is ready to ramp up again with much, much better management and strategy, including a presence in public […]
I end up covering a large number of stocks here at Stock Gumshoe, so even though a very small number of them end up getting featured as an “Idea of the Month” that I like, or as a stock that I buy personally, there are usually quite a few of even these “favored” names that […]
Time, once again, for the Annual Review of all of the stocks I hold in the Real Money Portfolio. Many of my positions are built up over many years, and sometimes they’re stocks that don’t generate a lot of news or attention for months at a time, so I promise each January to cover every […]
Over the years I’ve shared a few “Idea of the Month” picks that are plays on various emerging markets — the most direct emerging and frontier market picks have been Lonrho in Africa, Brazil Fast Food in Brazil, and Nagacorp in Cambodia, so let’s check in with those. As with the rest of our annual […]
It’s been a wild week. The mood was still pretty upbeat on Monday and Tuesday, a little anxiety but a lot of complacency (including mine)… I was in Toronto early this week, with plenty of hand washing and hand sanitizer but no real signs of panic or changes in lifestyle for most folks — the […]
This Company is About to Smash a Mobile Crime RingANY IDEAS ? This fellow (AND others) are teasing this same stock…………… * Meet one of todayâs most underhanded crooks. One whose epic crime spree results in $190 billion being stolen from unsuspecting people every year. Iâm not talking about a shady banker, or corrupt politician. Iâm not talking about a common street thug, either. […]
Well, we finish out the week with yet another dramatic performance from the market-dominating tech stocks. Alphabet (GOOG) did better than expected and popped a bit, climbing further through the day, almost as much as the gains Microsoft (MSFT) made on a more dramatic ‘beat’ of expectations (though analysts have always been better at estimating […]
Down 24.93% In the period from the 3rd of November up to including the 28th of March the stock went down 24.93% despite the 12% dividend growth and the 6% group revenue growth in 2017. Was the company really at its top performance in 2017 and is the price now thrown back to the real […]
Over the years I’ve shared a few “Idea of the Month” picks that are plays on various emerging markets — the most direct emerging and frontier market picks have been Lonrho in Africa, Brazil Fast Food in Brazil, and Nagacorp in Cambodia, so let’s check in with those. As with the rest of our annual […]
Things began slowly this week after a weekend of decadence in Las Vegas… what impressions did I have of Sin City? People aren’t gambling as much as the last time I was here a few years ago, the tables and slot machines were not so crowded, but there were still some big crowds of people […]
Over the years I’ve shared a few “Idea of the Month” picks that are plays on various emerging markets — the most direct emerging and frontier market picks have been Lonrho in Africa, Brazil Fast Food in Brazil, and Nagacorp in Cambodia, so let’s check in with those. As with the rest of our annual […]
The Value Investing Congress is always fun, and I’ll be trying to learn plenty that I can share with you in the weeks ahead (and, hopefully, become a better investor myself in the process), but this year I decided to spend a bit more time in New York and take in the pre-Congress seminar as […]
These are my notes and instant reactions from a presentation at the Value Investing Congress, the notes below might contain errors, paraphrases, incorrect quotes, or misinterpretations. Daniel Miller runs the “Focus five” portfolio at Gabelli, which is designed to overweight a small number of the very best ideas that that money management shop. They look […]
Whole Foods Market, which has been pushed by the Motley Fool Stock Advisor as their favorite pick, and as the “New American Super Brand” for as long as I can remember (when I wrote about this ad over a year ago the first instance of it I could find was from December 2006, when the […]
That “top stock” headline is the promise of Ian Wyatt, not myself, just to be clear. Wyatt and Taylor Laundon put out a letter called Top Stock Insights, the text of the ad for that letter says it’s from Taylor and the letter is “signed” by Ian Wyatt, so I guess we’ll assume it’s a […]
[ed. note: Gumshoe readers have been delighted with the biotech stock discussion led by one of our readers, who has gone by the name karmaswimswami as he has shared hundreds of useful comments — so we’ve asked him to come on as a formal contributor, he’ll be sharing a column with the Irregulars and talking […]
Well, after spending last month catching up and revising my thoughts and opinions about the dozens of stocks I’ve covered for the Irregulars in this space, it’s time to again look for something interesting for your consideration. First, I should let you know that I’ve become less worried about about Seadrill (SDRL) this week after […]
This discussion came about as the result of the GS thread ”This Tiny, Unknown Biotech is About to Unleash Its âHoly Grailâ Drug” It is hoped that all/any that can throw light, can brainstorm here and feedback consensus to the thread. Good work Guys. my best Alan Harris.
[Ed. note: Today we have another article from Jim Skelton, the Blind Squirrel, who is sharing his experiences as a financial advisor with us. He has agreed to our trading restrictions, the opinions he expresses are his own, and we haven’t reviewed, approved or screened his ideas. His previous articles can be seen here.] Hello, fellow […]
[Ed note: Following is another installment from our favorite medical scribe, “Doc Gumshoe” (no, he’s not a doctor). We feature Michael’s commentary every couple weeks or so, and his thoughts and words are his own. “Doc” doesn’t pick stocks, but FDA decisions are a huge driver of investment success for pharmaceutical and biotech companies and […]
“My Top-Secret Recommendation â Already Growing at 20% â Is Positioned to Score Huge Profits from the UAV Drone and 3-D Markets” That was the part of Stephen Leeb’s latest pitch that caught my attention — though, to be clear, that somewhat specific little hint came way down near the end of the presentation. Before […]
[Ed. note: Here is our latest contribution from longtime reader Myron Martin. He has agreed to our trading restrictions, and, as usual, we have not reviewed, approved or screened his stocks or ideas, and the opinions he expresses are solely his own.  Many of the stocks Myron covers are microcap âpenny stocksâ that can move dramatically […]
I’ll warn you up front: if you’ve been sailing the seas with us here on the good ship Gumshoe for more than a couple years, you’ve already seen this one. But Benjamin Shepherd at the Global Investment Strategist is now saying that it’s “The One Stock You Must Buy in 2014” so I thought we […]
Well, we took a brief break yesterday but I’m now back at it — looking at Hilary Kramer’s “Barn Burner” pitches for her Breakout Stocks Under $10 newsletter. The basic idea, if you’ll recall, is that she’s picking low-priced stocks (that’s the “Under $10” part) that she thinks will break out either because they are […]
[ed. note: Michael Jorrin, a longtime medical writer who has earned the nickname “Doc Gumshoe” despite his lack of a stethoscope and medical diploma, is our favorite scribe on all topics health related — we feature his columns every couple weeks here at Stock Gumshoe to help us bring some skepticism and plain speaking to […]
I end up covering a large number of stocks here at Stock Gumshoe, so even though a very small number of them end up getting featured as an “Idea of the Month” that I like, or as a stock that I buy personally, there are usually quite a few of even these “favored” names that […]
Robert Morris is helming a biotech-focused stock newsletter that’s called Biotech Supertrader (modesty has no place in the world of newsletter promotions, of course), and I’ve never covered this letter before so I thought I ought to have a look at the latest teaser we’ve been asked about. Morris, incidentally, has been featured in our […]
I’ve gotten quite a few questions about the latest pitch from Ian Wyatt for his $100K Portfolio newsletter — this is his letter that tracks the trades of a $100,000 real money portfolio of his own money, started up a couple years ago when every newsletter publisher was trying out a “real money” letter. I […]
This latest pitch coming through from the Wealth Daily folks, for Jimmy Mengel’s The Crow’s Nest advisory, has caught the attention of plenty of Gumshoe readers — it starts with a long spiel about tapping into the “secret” holdings of billionaires by using a SEC disclosure rule that these rich folks are all fighting tooth […]
[ed. note: We feature the writings of Doc Gumshoe, our favorite medical scribe, every few weeks here at Stock Gumshoe. He is not a doctor, but we value his insight, research, contrariness and skepticism … and, most importantly, his ability to explain complex health issues for our readers. You can see all of Michael’s previous […]
OK, so this one’s a bit tricky. And not just because the clues are a bit limited. Don’t worry, we’ll still find an answer for you … but a caveat or two first … Frank Curzio edits Phase 1 Investor, which is Stansberry’s “big ticket” newsletter that typically covers small tech, biotech and natural resources […]
It’s been an interesting week here in the Land of Gumshoe — Just this morning I’ve been patting myself on the back for suggesting that Africa Oil was a good deal again in the $7s a couple months ago (they just announced yet another oil find today, putting the shares up over $10 for the […]
[ed. note: We feature the writings of Doc Gumshoe, our favorite medical scribe, every few weeks here at Stock Gumshoe. He is not a doctor, but we value his insight, research, contrariness and skepticism … and, most importantly, his ability to explain complex health issues for our readers. He generates a lot of discussion with […]
Another Motley Fool growth stock to sniff out for you today … David Gardner has gotten a reputation as a compelling “rule breaking” growth stock picker over the past few decades, with some huge winners chosen (and held through very tumultuous times) as he built the Motley Fool with his brother Tom. The flagship Motley […]